bioRxivMolecular BiologyPreprint
Liquid biopsy in gastrointestinal stromal tumors -- Simultaneous detection of primary and secondary mutations with an NGS based circulating tumor DNA assay
N. Somasundaram, R. Quek, D. Ho, M. F. B. Harunal Ras, R. R. J. Lim, A. Gan, W. L. Tan, J. Y. Chan, E. Poon, C. W. Chua, J. Ong, C. Chia, G. Tan, M. Teo, W. L. Goh, W. J. Lim, J. Hong, I. B. Tan, S. B. Ng
Abstract
Introduction Introduction Methods Results Discussion References Gastrointestinal Stromal tumors (GISTs) are the most common neoplasms of mesenchymal origin arising from the gastrointestinal tract. GISTs are mostly characterised by one predominant activating mutation in KIT (KIT proto-oncogene receptor tyrosine kinase) or PDGFRA (platelet derived growth factor receptor alpha) genes1-3. Under pharmacological pressure, one or more secondary mutations can develop in KIT, conferring resistance to tyrosine kinase inhibitor, imatinib. In imatinib-resistant GISTs, secondary mutations can occur in the ATP binding pocket, encoded by exons 13 and 14 or in the kinase activation loop, encoded predominantly by exon 174. In vitro studies ha ...
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systematic elucidation and pharmacologic targeting of non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumor
Prabhjot Singh Mundi, Adina Grunn, … Andrea Califano·bioRxiv·Oct 12, 2025
- Targeting the translational machinery in gastrointestinal stromal tumors (GIST) - a new therapeutic vulnerability
D. M. Lee, A. Sun, … A. Duensing·bioRxiv·Sep 1, 2021
- Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells
J. L. Rausch, A. A. Ali, … A. Duensing·bioRxiv·Jan 9, 2020
- Identification of Wee1 as Target in Combination with Avapritinib for the Treatment of Gastrointestinal Stromal Tumors
S. Ye, D. Sharipova, … L. Rink·bioRxiv·Jun 7, 2020
- Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor
M. Kozinova, S. Joshi, … L. Rink·bioRxiv·Apr 13, 2021
- Golgi retention of KIT in gastrointestinal stromal tumour cells is phospholipase D activity-dependent
Yuuki Obata, Miyuki Natsume, … Toshirou Nishida·Scientific ReportsPeer-reviewed·Aug 6, 2025